21 CFR Subpart C
Index of Legally Marketed Unapproved New Animal Drugs for Minor Species
June 25, 2020
§
516.117
Submission of correspondence under this subpart
§
516.111
Scope of this subpart
§
516.115
Definitions
§
516.119
Permanent-resident U.S. agent for foreign requestors and holders
§
516.121
Meetings
§
516.123
Informal conferences regarding agency administrative actions
§
516.125
Investigational use of minor species new animal drugs to support indexing
§
516.129
Content and format of a request for determination of eligibility for indexing
§
516.131
Refuse to file a request for determination of eligibility for indexing
§
516.133
Denying a request for determination of eligibility for indexing
§
516.135
Granting a request for determination of eligibility for indexing
§
516.137
Notification of decision regarding eligibility for indexing
§
516.141
Qualified expert panels
§
516.143
Written report
§
516.145
Content and format of a request for addition to the index
§
516.147
Refuse to file a request for addition to the index
§
516.149
Denying a request for addition to the index
§
516.151
Granting a request for addition to the index
§
516.153
Notification of decision regarding index listing
§
516.155
Labeling of indexed drugs
§
516.157
Publication of the index and content of an index listing
§
516.161
Modifications to indexed drugs
§
516.163
Change in ownership of an index file
§
516.165
Records and reports
§
516.167
Removal from the index
§
516.171
Confidentiality of data and information in an index file
Tried the LawStack mobile app?
Join thousands and try LawStack mobile for FREE today.
- Carry the law offline, wherever you go.
- Download CFR, USC, rules, and state law to your mobile device.
